Evidence map›Paper›PMID 35214901›Full record

ArticlePlants (Basel, Switzerland)2022

Effective Utilization of

Hisahiro Kai, Kazuhiro Sugamoto, Saki Toshima, Yo Goto, Takayuki Nakayama, Kazuhiro Morishita, Hisato Kunitake

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hisahiro KaiDepartment of Pharmaceutical Health Sciences, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka 882-8508, Japan.ORCID 0000-0003-3483-7231
Kazuhiro SugamotoDepartment of Applied Chemistry, Faculty of Engineering, University of Miyazaki, Miyazaki 889-2192, Japan.ORCID 0000-0002-0424-8308
Saki ToshimaDepartment of Biochemistry and Applied Biosciences, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Japan.
Yo GotoBiolabo Co., Ltd., Kobe 650-0047, Japan.
Takayuki NakayamaBiolabo Co., Ltd., Kobe 650-0047, Japan.
Kazuhiro MorishitaDivision of Tumor and Cellular Biochemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki 889-2192, Japan.
Hisato KunitakeDepartment of Biochemistry and Applied Biosciences, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Japan.ORCID 0000-0003-0321-623X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that rabbit-eye blueberry (

Indexed as

adult T cell leukemia (ATL)antioxidant activityproanthocyanidin (PAC)stemVaccinium virgatum

Identifiers

PMID35214901
PMCPMC8880001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.